| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 450 | 2024 | 8725 | 17.630 |
Why?
|
| tau Proteins | 134 | 2024 | 2111 | 17.180 |
Why?
|
| Plaque, Amyloid | 103 | 2024 | 771 | 11.700 |
Why?
|
| Neurofibrillary Tangles | 93 | 2024 | 457 | 11.400 |
Why?
|
| Amyloid beta-Peptides | 186 | 2024 | 3894 | 10.270 |
Why?
|
| Tauopathies | 36 | 2024 | 325 | 7.490 |
Why?
|
| Amyloid beta-Protein Precursor | 103 | 2020 | 1116 | 7.270 |
Why?
|
| Apolipoproteins E | 87 | 2024 | 1458 | 6.280 |
Why?
|
| Neurons | 172 | 2024 | 9521 | 5.730 |
Why?
|
| Brain | 245 | 2024 | 27178 | 5.190 |
Why?
|
| Mice, Transgenic | 146 | 2024 | 9548 | 3.990 |
Why?
|
| Astrocytes | 28 | 2024 | 1345 | 3.660 |
Why?
|
| Apolipoprotein E4 | 42 | 2024 | 707 | 3.220 |
Why?
|
| Amyloid | 31 | 2024 | 849 | 3.140 |
Why?
|
| Microglia | 31 | 2024 | 1370 | 3.000 |
Why?
|
| alpha-Synuclein | 55 | 2023 | 771 | 2.970 |
Why?
|
| Lewy Body Disease | 23 | 2024 | 255 | 2.950 |
Why?
|
| Presenilin-1 | 58 | 2021 | 665 | 2.670 |
Why?
|
| Apolipoprotein E2 | 11 | 2024 | 133 | 2.540 |
Why?
|
| Hippocampus | 77 | 2023 | 3774 | 2.530 |
Why?
|
| Nerve Tissue Proteins | 52 | 2024 | 4391 | 2.520 |
Why?
|
| Disease Models, Animal | 108 | 2024 | 18289 | 2.380 |
Why?
|
| Synapses | 32 | 2021 | 1755 | 2.300 |
Why?
|
| Neurites | 28 | 2015 | 389 | 2.180 |
Why?
|
| Endopeptidases | 23 | 2009 | 759 | 2.120 |
Why?
|
| Nerve Degeneration | 20 | 2020 | 748 | 2.090 |
Why?
|
| Mice | 252 | 2024 | 81788 | 2.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 23 | 2017 | 415 | 2.010 |
Why?
|
| Dendritic Spines | 12 | 2013 | 244 | 1.950 |
Why?
|
| Animals | 361 | 2024 | 168730 | 1.950 |
Why?
|
| Entorhinal Cortex | 15 | 2023 | 285 | 1.930 |
Why?
|
| Caspases | 11 | 2014 | 880 | 1.820 |
Why?
|
| Peptide Fragments | 46 | 2021 | 5127 | 1.700 |
Why?
|
| Temporal Lobe | 31 | 2016 | 1715 | 1.700 |
Why?
|
| Lewy Bodies | 20 | 2012 | 140 | 1.670 |
Why?
|
| Cerebral Cortex | 53 | 2024 | 5764 | 1.550 |
Why?
|
| Neurodegenerative Diseases | 19 | 2024 | 1086 | 1.480 |
Why?
|
| Aging | 55 | 2022 | 8731 | 1.450 |
Why?
|
| Aspartic Acid Endopeptidases | 23 | 2015 | 309 | 1.430 |
Why?
|
| Supranuclear Palsy, Progressive | 5 | 2024 | 82 | 1.350 |
Why?
|
| Amyloid Precursor Protein Secretases | 40 | 2021 | 618 | 1.340 |
Why?
|
| Membrane Proteins | 40 | 2011 | 7846 | 1.330 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 16 | 2015 | 265 | 1.330 |
Why?
|
| Apolipoprotein E3 | 14 | 2022 | 104 | 1.330 |
Why?
|
| Humans | 645 | 2024 | 765823 | 1.330 |
Why?
|
| Phosphorylation | 45 | 2024 | 8278 | 1.310 |
Why?
|
| Transfection | 46 | 2015 | 5742 | 1.280 |
Why?
|
| Receptors, LDL | 15 | 2011 | 491 | 1.270 |
Why?
|
| Microscopy, Fluorescence | 25 | 2013 | 2626 | 1.270 |
Why?
|
| Parkinson Disease | 35 | 2023 | 2891 | 1.250 |
Why?
|
| Neuronal Plasticity | 15 | 2021 | 1444 | 1.240 |
Why?
|
| Aged, 80 and over | 161 | 2024 | 59506 | 1.210 |
Why?
|
| Prions | 4 | 2024 | 177 | 1.200 |
Why?
|
| Visual Cortex | 7 | 2021 | 1084 | 1.190 |
Why?
|
| Antibodies | 11 | 2023 | 2415 | 1.120 |
Why?
|
| Immunohistochemistry | 75 | 2023 | 11033 | 1.100 |
Why?
|
| Dependovirus | 13 | 2021 | 721 | 1.080 |
Why?
|
| Dementia | 30 | 2022 | 2743 | 1.030 |
Why?
|
| Brain Chemistry | 18 | 2012 | 952 | 0.980 |
Why?
|
| Cerebral Amyloid Angiopathy | 18 | 2023 | 885 | 0.970 |
Why?
|
| Substantia Nigra | 13 | 2013 | 346 | 0.960 |
Why?
|
| Synaptophysin | 10 | 2020 | 137 | 0.960 |
Why?
|
| LDL-Receptor Related Proteins | 9 | 2024 | 118 | 0.960 |
Why?
|
| Aged | 252 | 2024 | 171178 | 0.950 |
Why?
|
| Calcineurin | 5 | 2019 | 233 | 0.950 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2020 | 179 | 0.950 |
Why?
|
| Green Fluorescent Proteins | 30 | 2018 | 2060 | 0.940 |
Why?
|
| Protein Isoforms | 18 | 2022 | 1717 | 0.940 |
Why?
|
| Receptors, Immunologic | 15 | 2017 | 1415 | 0.920 |
Why?
|
| RNA, Messenger | 41 | 2024 | 12767 | 0.910 |
Why?
|
| Synucleins | 22 | 2005 | 108 | 0.880 |
Why?
|
| Dominance, Ocular | 2 | 2021 | 30 | 0.880 |
Why?
|
| Cells, Cultured | 70 | 2024 | 18970 | 0.870 |
Why?
|
| Inclusion Bodies | 13 | 2020 | 276 | 0.870 |
Why?
|
| Axons | 16 | 2024 | 1678 | 0.870 |
Why?
|
| Disease Progression | 38 | 2024 | 13613 | 0.860 |
Why?
|
| Cognition Disorders | 24 | 2020 | 3966 | 0.840 |
Why?
|
| Frontotemporal Dementia | 6 | 2024 | 248 | 0.840 |
Why?
|
| Amyotrophic Lateral Sclerosis | 9 | 2024 | 1481 | 0.820 |
Why?
|
| Dendrites | 11 | 2012 | 469 | 0.820 |
Why?
|
| Neurofibrils | 12 | 2006 | 75 | 0.810 |
Why?
|
| Gliosis | 10 | 2024 | 246 | 0.800 |
Why?
|
| Receptors, Cell Surface | 12 | 2009 | 2817 | 0.790 |
Why?
|
| Proteasome Endopeptidase Complex | 10 | 2021 | 1313 | 0.790 |
Why?
|
| HSP70 Heat-Shock Proteins | 9 | 2015 | 393 | 0.780 |
Why?
|
| Vision, Ocular | 2 | 2017 | 457 | 0.760 |
Why?
|
| Protein Multimerization | 9 | 2016 | 959 | 0.760 |
Why?
|
| Blood-Brain Barrier | 7 | 2022 | 1037 | 0.750 |
Why?
|
| Ubiquitin | 5 | 2012 | 839 | 0.750 |
Why?
|
| Gene Expression Regulation | 26 | 2021 | 11888 | 0.740 |
Why?
|
| Protein Structure, Tertiary | 31 | 2014 | 3749 | 0.720 |
Why?
|
| Molecular Chaperones | 10 | 2018 | 761 | 0.710 |
Why?
|
| Biosensing Techniques | 2 | 2024 | 642 | 0.710 |
Why?
|
| Male | 241 | 2024 | 363740 | 0.710 |
Why?
|
| National Institute on Aging (U.S.) | 6 | 2024 | 40 | 0.710 |
Why?
|
| Cell Nucleus | 12 | 2018 | 2864 | 0.710 |
Why?
|
| Microscopy | 9 | 2016 | 900 | 0.710 |
Why?
|
| Protein Interaction Mapping | 5 | 2008 | 619 | 0.710 |
Why?
|
| Alternative Splicing | 7 | 2007 | 1106 | 0.710 |
Why?
|
| Mutation | 54 | 2024 | 30188 | 0.690 |
Why?
|
| Presynaptic Terminals | 5 | 2017 | 297 | 0.680 |
Why?
|
| Alleles | 37 | 2021 | 6893 | 0.680 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 27 | 2015 | 3802 | 0.670 |
Why?
|
| Enzyme Activation | 11 | 2014 | 3585 | 0.660 |
Why?
|
| Female | 228 | 2024 | 396050 | 0.650 |
Why?
|
| Polymorphism, Genetic | 16 | 2006 | 4249 | 0.650 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2024 | 4036 | 0.650 |
Why?
|
| Olfactory Pathways | 4 | 2017 | 131 | 0.640 |
Why?
|
| Gene Expression | 24 | 2020 | 7581 | 0.640 |
Why?
|
| Microscopy, Confocal | 21 | 2017 | 1965 | 0.630 |
Why?
|
| HEK293 Cells | 13 | 2021 | 4255 | 0.630 |
Why?
|
| Protein Transport | 20 | 2024 | 1937 | 0.630 |
Why?
|
| Down Syndrome | 8 | 2017 | 915 | 0.620 |
Why?
|
| Mice, Inbred C57BL | 44 | 2021 | 22323 | 0.610 |
Why?
|
| Cricetinae | 29 | 2011 | 2412 | 0.610 |
Why?
|
| Protein Binding | 35 | 2024 | 9297 | 0.600 |
Why?
|
| Protein Processing, Post-Translational | 11 | 2024 | 1959 | 0.600 |
Why?
|
| Protein Structure, Quaternary | 7 | 2023 | 423 | 0.590 |
Why?
|
| Immunization, Passive | 4 | 2009 | 616 | 0.590 |
Why?
|
| CHO Cells | 24 | 2024 | 1372 | 0.580 |
Why?
|
| Carrier Proteins | 15 | 2011 | 4911 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2021 | 18064 | 0.580 |
Why?
|
| Cytoplasm | 11 | 2021 | 1497 | 0.570 |
Why?
|
| Receptors, Lipoprotein | 6 | 2007 | 87 | 0.570 |
Why?
|
| Neurotoxins | 12 | 2006 | 238 | 0.570 |
Why?
|
| Blotting, Western | 23 | 2014 | 5018 | 0.570 |
Why?
|
| Carbolines | 5 | 2017 | 288 | 0.570 |
Why?
|
| Cytoskeletal Proteins | 5 | 2017 | 1322 | 0.570 |
Why?
|
| Genotype | 54 | 2021 | 13023 | 0.560 |
Why?
|
| Cell Death | 12 | 2024 | 1678 | 0.550 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2015 | 298 | 0.550 |
Why?
|
| Cerebrovascular Circulation | 5 | 2023 | 2674 | 0.550 |
Why?
|
| Cricetulus | 15 | 2024 | 806 | 0.550 |
Why?
|
| Luciferases | 8 | 2011 | 713 | 0.550 |
Why?
|
| Cell Count | 19 | 2013 | 1823 | 0.540 |
Why?
|
| Receptors, Chemokine | 6 | 2008 | 651 | 0.540 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 550 | 0.540 |
Why?
|
| Neocortex | 9 | 2017 | 414 | 0.540 |
Why?
|
| Protein Conformation | 19 | 2017 | 3945 | 0.530 |
Why?
|
| Transcription Factors | 10 | 2021 | 12122 | 0.530 |
Why?
|
| Apoptosis | 14 | 2014 | 9512 | 0.530 |
Why?
|
| Cell Line | 39 | 2020 | 15540 | 0.530 |
Why?
|
| NFATC Transcription Factors | 4 | 2018 | 391 | 0.520 |
Why?
|
| Nerve Net | 7 | 2018 | 2310 | 0.520 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2018 | 254 | 0.510 |
Why?
|
| Cell Membrane | 12 | 2018 | 3633 | 0.510 |
Why?
|
| Pick Disease of the Brain | 3 | 2024 | 42 | 0.500 |
Why?
|
| Subcellular Fractions | 7 | 2012 | 528 | 0.500 |
Why?
|
| Smell | 2 | 2017 | 259 | 0.490 |
Why?
|
| Caspase 3 | 7 | 2017 | 731 | 0.490 |
Why?
|
| Thiazoles | 11 | 2015 | 1529 | 0.490 |
Why?
|
| In Situ Hybridization | 14 | 2020 | 1885 | 0.480 |
Why?
|
| ADP-Ribosylation Factors | 2 | 2006 | 130 | 0.480 |
Why?
|
| Protein Folding | 10 | 2017 | 868 | 0.480 |
Why?
|
| Neural Pathways | 15 | 2014 | 3087 | 0.480 |
Why?
|
| Glial Fibrillary Acidic Protein | 12 | 2020 | 564 | 0.470 |
Why?
|
| Age of Onset | 18 | 2020 | 3341 | 0.470 |
Why?
|
| Endocytosis | 13 | 2020 | 951 | 0.470 |
Why?
|
| Amyloidosis | 6 | 2019 | 884 | 0.470 |
Why?
|
| Atrophy | 12 | 2024 | 1629 | 0.470 |
Why?
|
| Luminescent Proteins | 8 | 2014 | 839 | 0.470 |
Why?
|
| AIDS-Related Complex | 1 | 2014 | 107 | 0.460 |
Why?
|
| RNA Probes | 2 | 2014 | 110 | 0.460 |
Why?
|
| Calcium-Binding Proteins | 7 | 2018 | 1077 | 0.440 |
Why?
|
| Middle Aged | 139 | 2024 | 223016 | 0.440 |
Why?
|
| Membrane Transport Proteins | 5 | 2024 | 1029 | 0.430 |
Why?
|
| Neuroglia | 9 | 2023 | 964 | 0.430 |
Why?
|
| Methylene Blue | 1 | 2014 | 157 | 0.430 |
Why?
|
| Adaptor Proteins, Signal Transducing | 15 | 2017 | 2896 | 0.430 |
Why?
|
| Mitochondria | 10 | 2021 | 3670 | 0.420 |
Why?
|
| Memory Disorders | 10 | 2016 | 1193 | 0.420 |
Why?
|
| Visual Pathways | 1 | 2017 | 556 | 0.420 |
Why?
|
| alpha-Macroglobulins | 6 | 2002 | 60 | 0.420 |
Why?
|
| Neuropsychological Tests | 22 | 2021 | 7119 | 0.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2014 | 1657 | 0.420 |
Why?
|
| Corpus Striatum | 13 | 2024 | 1218 | 0.410 |
Why?
|
| Hydrocephalus, Normal Pressure | 2 | 2024 | 101 | 0.410 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 163 | 0.410 |
Why?
|
| Cerebrum | 1 | 2014 | 132 | 0.400 |
Why?
|
| Nuclear Proteins | 9 | 2013 | 5781 | 0.400 |
Why?
|
| Heterozygote | 4 | 2020 | 2795 | 0.400 |
Why?
|
| Recombinant Fusion Proteins | 13 | 2013 | 3736 | 0.400 |
Why?
|
| Flow Cytometry | 5 | 2018 | 5879 | 0.400 |
Why?
|
| Cell Compartmentation | 4 | 2010 | 383 | 0.390 |
Why?
|
| Autopsy | 12 | 2019 | 1012 | 0.390 |
Why?
|
| Sensory Deprivation | 2 | 2012 | 109 | 0.390 |
Why?
|
| Macromolecular Substances | 8 | 2004 | 1430 | 0.390 |
Why?
|
| Benzothiazoles | 8 | 2018 | 246 | 0.390 |
Why?
|
| Cognition | 16 | 2022 | 7045 | 0.390 |
Why?
|
| Introns | 6 | 2011 | 965 | 0.380 |
Why?
|
| Rats | 50 | 2022 | 23707 | 0.380 |
Why?
|
| Culture Media, Conditioned | 6 | 2018 | 521 | 0.380 |
Why?
|
| Autoantibodies | 5 | 2016 | 2112 | 0.380 |
Why?
|
| Tubulin | 4 | 2017 | 692 | 0.370 |
Why?
|
| Immunoblotting | 9 | 2016 | 1643 | 0.370 |
Why?
|
| Axonal Transport | 2 | 2024 | 178 | 0.370 |
Why?
|
| Calcium Signaling | 6 | 2019 | 733 | 0.360 |
Why?
|
| Molecular Weight | 9 | 2018 | 2162 | 0.360 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 1999 | 490 | 0.350 |
Why?
|
| Biopolymers | 1 | 2011 | 181 | 0.350 |
Why?
|
| Genetic Complementation Test | 1 | 2011 | 557 | 0.350 |
Why?
|
| Spectrometry, Fluorescence | 10 | 2005 | 697 | 0.340 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 1175 | 0.340 |
Why?
|
| Preoperative Care | 3 | 2017 | 2244 | 0.340 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2014 | 878 | 0.340 |
Why?
|
| Tacrolimus | 2 | 2010 | 754 | 0.340 |
Why?
|
| Regeneration | 1 | 2019 | 1516 | 0.340 |
Why?
|
| Cell Survival | 12 | 2021 | 5747 | 0.330 |
Why?
|
| Proteostasis Deficiencies | 2 | 2020 | 38 | 0.330 |
Why?
|
| Immunoassay | 1 | 2013 | 742 | 0.330 |
Why?
|
| Point Mutation | 4 | 2004 | 1590 | 0.330 |
Why?
|
| Multifactorial Inheritance | 5 | 2019 | 1426 | 0.330 |
Why?
|
| Dopamine | 9 | 2009 | 1583 | 0.330 |
Why?
|
| Membrane Glycoproteins | 10 | 2017 | 3690 | 0.330 |
Why?
|
| Positron-Emission Tomography | 16 | 2022 | 6545 | 0.330 |
Why?
|
| Exons | 7 | 2022 | 2391 | 0.330 |
Why?
|
| Chemokines, CXC | 2 | 2002 | 416 | 0.330 |
Why?
|
| Calcium | 11 | 2019 | 5767 | 0.320 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2024 | 1884 | 0.320 |
Why?
|
| Genetic Vectors | 11 | 2018 | 3404 | 0.320 |
Why?
|
| Genome-Wide Association Study | 18 | 2024 | 12800 | 0.320 |
Why?
|
| Biophysical Phenomena | 5 | 2018 | 318 | 0.320 |
Why?
|
| Alkenes | 4 | 2008 | 54 | 0.320 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 275 | 0.320 |
Why?
|
| Nervous System | 1 | 2012 | 542 | 0.310 |
Why?
|
| Neuropil | 5 | 2003 | 31 | 0.310 |
Why?
|
| Homozygote | 6 | 2020 | 1774 | 0.310 |
Why?
|
| Huntington Disease | 4 | 2024 | 1147 | 0.310 |
Why?
|
| Lysosomes | 5 | 2012 | 932 | 0.310 |
Why?
|
| Ligands | 17 | 2020 | 3273 | 0.310 |
Why?
|
| Animals, Genetically Modified | 5 | 2011 | 1558 | 0.300 |
Why?
|
| Cell Line, Tumor | 27 | 2024 | 17063 | 0.300 |
Why?
|
| Frontotemporal Lobar Degeneration | 4 | 2015 | 102 | 0.300 |
Why?
|
| Practice Guidelines as Topic | 4 | 2019 | 7416 | 0.300 |
Why?
|
| Neurosciences | 3 | 2019 | 385 | 0.300 |
Why?
|
| Base Sequence | 24 | 2015 | 12402 | 0.300 |
Why?
|
| Enzyme Inhibitors | 11 | 2013 | 3716 | 0.300 |
Why?
|
| Endosomes | 5 | 2005 | 522 | 0.290 |
Why?
|
| Oxidative Stress | 11 | 2021 | 3139 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2024 | 36542 | 0.290 |
Why?
|
| Embryo, Mammalian | 11 | 2011 | 1673 | 0.290 |
Why?
|
| Drug Discovery | 2 | 2021 | 1063 | 0.290 |
Why?
|
| Fluorescent Dyes | 12 | 2014 | 1929 | 0.290 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2017 | 2744 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 23 | 2014 | 8105 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 20 | 2017 | 9241 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 20 | 2017 | 8927 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 1240 | 0.280 |
Why?
|
| Receptor, Notch1 | 9 | 2009 | 517 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 5 | 2021 | 1475 | 0.280 |
Why?
|
| Gene Expression Profiling | 11 | 2024 | 9520 | 0.280 |
Why?
|
| Models, Neurological | 7 | 2020 | 1748 | 0.270 |
Why?
|
| Heat-Shock Proteins | 4 | 2008 | 790 | 0.270 |
Why?
|
| Synaptotagmin I | 2 | 2017 | 33 | 0.270 |
Why?
|
| Tyrosine | 5 | 2009 | 1427 | 0.260 |
Why?
|
| Tomography, Emission-Computed | 4 | 2003 | 1006 | 0.260 |
Why?
|
| Caregivers | 4 | 2023 | 2304 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2015 | 1894 | 0.260 |
Why?
|
| Chromatography, Gel | 4 | 2021 | 629 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2021 | 16040 | 0.260 |
Why?
|
| Longitudinal Studies | 25 | 2021 | 14745 | 0.260 |
Why?
|
| Reference Values | 15 | 2013 | 4911 | 0.260 |
Why?
|
| Staining and Labeling | 6 | 2023 | 1071 | 0.260 |
Why?
|
| Genes, Reporter | 7 | 2009 | 1524 | 0.250 |
Why?
|
| Phosphotransferases | 2 | 1997 | 302 | 0.250 |
Why?
|
| Societies, Medical | 4 | 2013 | 3950 | 0.250 |
Why?
|
| Postmortem Changes | 5 | 2010 | 119 | 0.250 |
Why?
|
| Leucine | 4 | 2014 | 546 | 0.250 |
Why?
|
| Electron Transport Complex IV | 3 | 1995 | 188 | 0.250 |
Why?
|
| Neuroaxonal Dystrophies | 3 | 2008 | 26 | 0.250 |
Why?
|
| Glioma | 8 | 2009 | 3493 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 7 | 2009 | 896 | 0.240 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2019 | 791 | 0.240 |
Why?
|
| Golgi Apparatus | 5 | 2010 | 405 | 0.240 |
Why?
|
| Binding, Competitive | 6 | 2005 | 1140 | 0.240 |
Why?
|
| Haplotypes | 6 | 2020 | 2728 | 0.240 |
Why?
|
| Extracellular Space | 3 | 2010 | 564 | 0.240 |
Why?
|
| Molecular Sequence Data | 26 | 2014 | 17595 | 0.240 |
Why?
|
| TYK2 Kinase | 1 | 2024 | 38 | 0.240 |
Why?
|
| Subtraction Technique | 1 | 2008 | 513 | 0.240 |
Why?
|
| Serine | 5 | 2023 | 824 | 0.230 |
Why?
|
| Transcription, Genetic | 6 | 2024 | 7599 | 0.230 |
Why?
|
| Fluorescence | 4 | 2012 | 753 | 0.230 |
Why?
|
| Extracellular Fluid | 3 | 2016 | 165 | 0.230 |
Why?
|
| Quinones | 1 | 2004 | 78 | 0.230 |
Why?
|
| Case-Control Studies | 25 | 2020 | 22227 | 0.230 |
Why?
|
| Genetic Loci | 5 | 2021 | 2631 | 0.230 |
Why?
|
| Proline | 3 | 2024 | 453 | 0.230 |
Why?
|
| Population Surveillance | 1 | 2015 | 2595 | 0.230 |
Why?
|
| Receptors, Interleukin-8B | 2 | 2002 | 58 | 0.230 |
Why?
|
| Cohort Studies | 28 | 2021 | 41643 | 0.230 |
Why?
|
| Phenotype | 16 | 2023 | 16706 | 0.230 |
Why?
|
| Microfilament Proteins | 3 | 2018 | 1130 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2009 | 1678 | 0.220 |
Why?
|
| Olfactory Perception | 2 | 2016 | 64 | 0.220 |
Why?
|
| Dinoprost | 2 | 2003 | 139 | 0.220 |
Why?
|
| Ubiquitins | 3 | 2000 | 365 | 0.220 |
Why?
|
| Translocation, Genetic | 1 | 2009 | 1393 | 0.220 |
Why?
|
| Benzodiazepinones | 2 | 2013 | 50 | 0.220 |
Why?
|
| Solubility | 7 | 2012 | 1078 | 0.220 |
Why?
|
| Age Factors | 19 | 2017 | 18380 | 0.220 |
Why?
|
| Mental Status Schedule | 6 | 2016 | 315 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 10 | 2011 | 6110 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 9 | 2013 | 4562 | 0.210 |
Why?
|
| Down-Regulation | 6 | 2009 | 2924 | 0.210 |
Why?
|
| Transgenes | 7 | 2016 | 1015 | 0.210 |
Why?
|
| Alzheimer Vaccines | 1 | 2003 | 25 | 0.210 |
Why?
|
| Nitric Oxide Synthase | 5 | 1997 | 911 | 0.210 |
Why?
|
| Recombinant Proteins | 8 | 2019 | 6489 | 0.210 |
Why?
|
| Nervous System Diseases | 6 | 2024 | 1658 | 0.210 |
Why?
|
| Interneurons | 3 | 2024 | 593 | 0.210 |
Why?
|
| Injections, Intraventricular | 5 | 2021 | 227 | 0.210 |
Why?
|
| Energy Transfer | 5 | 2004 | 108 | 0.210 |
Why?
|
| Aspartic Acid | 3 | 2009 | 575 | 0.210 |
Why?
|
| Prion Diseases | 1 | 2024 | 99 | 0.210 |
Why?
|
| Macrophage Inflammatory Proteins | 3 | 2000 | 121 | 0.200 |
Why?
|
| Olfactory Bulb | 4 | 2006 | 198 | 0.200 |
Why?
|
| Congo Red | 1 | 2002 | 49 | 0.200 |
Why?
|
| Amnesia | 2 | 2011 | 257 | 0.200 |
Why?
|
| Amino Acid Oxidoreductases | 2 | 1993 | 149 | 0.200 |
Why?
|
| Striatonigral Degeneration | 1 | 2002 | 13 | 0.200 |
Why?
|
| Photic Stimulation | 3 | 2014 | 1993 | 0.200 |
Why?
|
| Biological Assay | 3 | 2018 | 627 | 0.200 |
Why?
|
| Geriatric Assessment | 4 | 2017 | 1422 | 0.200 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 898 | 0.200 |
Why?
|
| Analysis of Variance | 9 | 2015 | 6204 | 0.200 |
Why?
|
| Neuroprotective Agents | 4 | 2021 | 958 | 0.200 |
Why?
|
| Biotinylation | 5 | 2010 | 184 | 0.200 |
Why?
|
| Severity of Illness Index | 16 | 2021 | 15881 | 0.200 |
Why?
|
| Benzene | 1 | 2002 | 106 | 0.190 |
Why?
|
| Gene Transfer Techniques | 2 | 2016 | 1216 | 0.190 |
Why?
|
| Tissue Distribution | 9 | 2012 | 2270 | 0.190 |
Why?
|
| Cholesterol | 7 | 2021 | 2898 | 0.190 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 544 | 0.190 |
Why?
|
| Time Factors | 25 | 2021 | 40109 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 15 | 2016 | 10723 | 0.190 |
Why?
|
| Histone Deacetylase 1 | 1 | 2022 | 133 | 0.190 |
Why?
|
| Central Nervous System | 3 | 2016 | 1342 | 0.190 |
Why?
|
| Cell Movement | 6 | 2016 | 5190 | 0.190 |
Why?
|
| Dizocilpine Maleate | 5 | 2000 | 171 | 0.190 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2015 | 446 | 0.190 |
Why?
|
| Photons | 6 | 2013 | 572 | 0.190 |
Why?
|
| Trinucleotide Repeats | 2 | 2007 | 257 | 0.190 |
Why?
|
| Multiple System Atrophy | 1 | 2023 | 132 | 0.190 |
Why?
|
| Neuroblastoma | 5 | 2018 | 1264 | 0.190 |
Why?
|
| Immunoprecipitation | 6 | 2012 | 871 | 0.190 |
Why?
|
| Binding Sites | 13 | 2013 | 5999 | 0.180 |
Why?
|
| Oligopeptides | 4 | 2012 | 1193 | 0.180 |
Why?
|
| Chemotactic Factors | 1 | 2002 | 195 | 0.180 |
Why?
|
| DNA, Complementary | 6 | 2012 | 1984 | 0.180 |
Why?
|
| Receptors, GABA | 2 | 2022 | 312 | 0.180 |
Why?
|
| Acetyltransferases | 1 | 2002 | 229 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 13 | 2015 | 6061 | 0.180 |
Why?
|
| Clinical Trials as Topic | 7 | 2024 | 8039 | 0.180 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 6 | 2010 | 425 | 0.180 |
Why?
|
| Sterilization | 1 | 2021 | 133 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2013 | 1440 | 0.180 |
Why?
|
| Aniline Compounds | 5 | 2015 | 1075 | 0.180 |
Why?
|
| Antibody Specificity | 4 | 2017 | 1060 | 0.180 |
Why?
|
| Signal Transduction | 13 | 2015 | 23588 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 679 | 0.180 |
Why?
|
| Biomedical Research | 2 | 2015 | 3457 | 0.180 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 5 | 2007 | 34 | 0.180 |
Why?
|
| Dopamine Agents | 4 | 1998 | 186 | 0.180 |
Why?
|
| Acetylcholinesterase | 2 | 2013 | 150 | 0.180 |
Why?
|
| Diagnostic Imaging | 6 | 2011 | 3527 | 0.170 |
Why?
|
| Limbic System | 5 | 2000 | 418 | 0.170 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2002 | 287 | 0.170 |
Why?
|
| Microvessels | 1 | 2024 | 589 | 0.170 |
Why?
|
| Gene Frequency | 13 | 2017 | 3623 | 0.170 |
Why?
|
| Dynamins | 2 | 2014 | 138 | 0.170 |
Why?
|
| Myeloid Cells | 2 | 2024 | 838 | 0.170 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 1999 | 13 | 0.170 |
Why?
|
| Microtubules | 3 | 2017 | 1062 | 0.170 |
Why?
|
| N-Methylaspartate | 6 | 2003 | 228 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2021 | 462 | 0.170 |
Why?
|
| Plasmids | 4 | 2012 | 2273 | 0.170 |
Why?
|
| DNA-Binding Proteins | 8 | 2024 | 9594 | 0.170 |
Why?
|
| Lipids | 5 | 2019 | 3316 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 4 | 2012 | 811 | 0.170 |
Why?
|
| Cell Communication | 3 | 2023 | 1660 | 0.170 |
Why?
|
| Nootropic Agents | 1 | 2021 | 159 | 0.170 |
Why?
|
| Cysteine Proteinase Inhibitors | 3 | 2010 | 186 | 0.170 |
Why?
|
| Actins | 3 | 2014 | 2057 | 0.170 |
Why?
|
| Protein Precursors | 2 | 1996 | 1133 | 0.170 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2016 | 1724 | 0.160 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1885 | 0.160 |
Why?
|
| Benzene Derivatives | 4 | 2008 | 51 | 0.160 |
Why?
|
| Growth Substances | 1 | 2002 | 758 | 0.160 |
Why?
|
| Cryoelectron Microscopy | 1 | 2023 | 645 | 0.160 |
Why?
|
| Glucosylceramidase | 1 | 2020 | 124 | 0.160 |
Why?
|
| Protease Nexins | 3 | 2009 | 39 | 0.160 |
Why?
|
| Multigene Family | 3 | 2015 | 1081 | 0.160 |
Why?
|
| Sensitivity and Specificity | 9 | 2013 | 14644 | 0.160 |
Why?
|
| Cell Cycle Proteins | 5 | 2011 | 3430 | 0.160 |
Why?
|
| Antigens, CD | 5 | 2011 | 4020 | 0.160 |
Why?
|
| Presenilin-2 | 5 | 2000 | 100 | 0.160 |
Why?
|
| Receptors, CCR5 | 2 | 1998 | 491 | 0.160 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2022 | 636 | 0.160 |
Why?
|
| Memory | 10 | 2020 | 2191 | 0.160 |
Why?
|
| Cytokines | 4 | 2018 | 7425 | 0.160 |
Why?
|
| Artifacts | 1 | 2008 | 1893 | 0.160 |
Why?
|
| Lipoproteins, VLDL | 2 | 1998 | 198 | 0.160 |
Why?
|
| Reproducibility of Results | 12 | 2022 | 20131 | 0.160 |
Why?
|
| Apolipoproteins | 2 | 1998 | 327 | 0.160 |
Why?
|
| Drugs, Investigational | 1 | 2021 | 211 | 0.160 |
Why?
|
| Sequence Analysis, Protein | 2 | 2018 | 261 | 0.160 |
Why?
|
| Up-Regulation | 6 | 2008 | 4133 | 0.160 |
Why?
|
| Microfluidic Analytical Techniques | 3 | 2017 | 788 | 0.160 |
Why?
|
| Structure-Activity Relationship | 10 | 2013 | 3053 | 0.160 |
Why?
|
| Receptors, Glutamate | 3 | 2001 | 227 | 0.160 |
Why?
|
| Zinc Fingers | 1 | 2021 | 576 | 0.150 |
Why?
|
| Amino Acid Motifs | 5 | 2010 | 924 | 0.150 |
Why?
|
| Clusterin | 3 | 2014 | 71 | 0.150 |
Why?
|
| Quantitative Trait Loci | 3 | 2022 | 2137 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 660 | 0.150 |
Why?
|
| Plant Proteins | 1 | 2001 | 375 | 0.150 |
Why?
|
| Mutation, Missense | 2 | 2015 | 2586 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 3 | 2004 | 1489 | 0.150 |
Why?
|
| Synaptosomes | 1 | 2018 | 116 | 0.150 |
Why?
|
| Stilbenes | 4 | 2008 | 154 | 0.150 |
Why?
|
| Lipoproteins | 4 | 1998 | 866 | 0.150 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2009 | 3359 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2017 | 2470 | 0.150 |
Why?
|
| Second Messenger Systems | 1 | 2019 | 204 | 0.150 |
Why?
|
| Presenilins | 4 | 2019 | 51 | 0.150 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 115 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2015 | 1150 | 0.150 |
Why?
|
| Brain Diseases | 4 | 2018 | 1551 | 0.150 |
Why?
|
| Amino Acid Sequence | 11 | 2018 | 13402 | 0.150 |
Why?
|
| Fibroblasts | 7 | 2018 | 4160 | 0.150 |
Why?
|
| Models, Molecular | 4 | 2013 | 5377 | 0.150 |
Why?
|
| Membrane Lipids | 2 | 2018 | 240 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2021 | 259 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2269 | 0.150 |
Why?
|
| Amino Acid Substitution | 5 | 2005 | 1739 | 0.150 |
Why?
|
| Oligonucleotide Probes | 5 | 1998 | 417 | 0.150 |
Why?
|
| Cerebral Veins | 2 | 2001 | 157 | 0.140 |
Why?
|
| Immunotherapy | 3 | 2004 | 4752 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 2021 | 765 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 4207 | 0.140 |
Why?
|
| Vaccination | 1 | 2010 | 3425 | 0.140 |
Why?
|
| NADPH Dehydrogenase | 3 | 1994 | 43 | 0.140 |
Why?
|
| DNA Primers | 7 | 2011 | 2823 | 0.140 |
Why?
|
| Metabolome | 1 | 2024 | 1005 | 0.140 |
Why?
|
| Algorithms | 8 | 2022 | 14062 | 0.140 |
Why?
|
| Craniotomy | 3 | 2010 | 731 | 0.140 |
Why?
|
| Exosomes | 3 | 2018 | 421 | 0.140 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2012 | 1065 | 0.140 |
Why?
|
| Genetic Linkage | 7 | 2007 | 2341 | 0.140 |
Why?
|
| Mice, Knockout | 17 | 2018 | 14445 | 0.140 |
Why?
|
| Multienzyme Complexes | 1 | 2001 | 663 | 0.140 |
Why?
|
| Transcriptional Activation | 6 | 2018 | 1743 | 0.140 |
Why?
|
| Dimerization | 5 | 2006 | 880 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2008 | 2859 | 0.140 |
Why?
|
| Brain Injuries | 2 | 1999 | 2061 | 0.140 |
Why?
|
| Neurobehavioral Manifestations | 1 | 1996 | 10 | 0.140 |
Why?
|
| Parietal Lobe | 3 | 2021 | 859 | 0.140 |
Why?
|
| Radiopharmaceuticals | 4 | 2017 | 2700 | 0.140 |
Why?
|
| Phospholipase C gamma | 1 | 2017 | 130 | 0.140 |
Why?
|
| Blood Vessels | 3 | 2018 | 1114 | 0.140 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2021 | 302 | 0.140 |
Why?
|
| Microcirculation | 2 | 2001 | 1279 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1999 | 3604 | 0.140 |
Why?
|
| Consensus Development Conferences, NIH as Topic | 2 | 2012 | 29 | 0.140 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 735 | 0.130 |
Why?
|
| Cathepsin D | 2 | 2010 | 59 | 0.130 |
Why?
|
| Superoxide Dismutase | 3 | 2011 | 593 | 0.130 |
Why?
|
| Neostriatum | 1 | 2017 | 231 | 0.130 |
Why?
|
| Glycogen Synthase | 1 | 1996 | 62 | 0.130 |
Why?
|
| Microscopy, Electron | 6 | 2013 | 2546 | 0.130 |
Why?
|
| Autoradiography | 5 | 2017 | 723 | 0.130 |
Why?
|
| Activities of Daily Living | 5 | 2023 | 2415 | 0.130 |
Why?
|
| Mice, Inbred C3H | 1 | 2017 | 915 | 0.130 |
Why?
|
| Patient Preference | 2 | 2023 | 947 | 0.130 |
Why?
|
| Mermithoidea | 1 | 2015 | 2 | 0.130 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 419 | 0.130 |
Why?
|
| Interferon-beta | 1 | 2018 | 346 | 0.130 |
Why?
|
| Inflammation | 8 | 2020 | 10845 | 0.130 |
Why?
|
| Propionates | 2 | 1993 | 180 | 0.130 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 243 | 0.130 |
Why?
|
| Cerebral Arteries | 2 | 1998 | 490 | 0.130 |
Why?
|
| Immunoenzyme Techniques | 7 | 2010 | 1697 | 0.130 |
Why?
|
| Movement Disorders | 2 | 2014 | 460 | 0.130 |
Why?
|
| Voluntary Health Agencies | 1 | 2015 | 38 | 0.130 |
Why?
|
| Protein Structure, Secondary | 4 | 2016 | 1210 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2010 | 605 | 0.130 |
Why?
|
| Primates | 1 | 1998 | 518 | 0.120 |
Why?
|
| Neuropeptides | 3 | 1998 | 951 | 0.120 |
Why?
|
| Epitopes | 4 | 2017 | 2523 | 0.120 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 1983 | 538 | 0.120 |
Why?
|
| Guanosine Triphosphate | 2 | 2014 | 313 | 0.120 |
Why?
|
| Caspase 6 | 1 | 2015 | 15 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.120 |
Why?
|
| Exocytosis | 1 | 2017 | 323 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 2 | 2006 | 283 | 0.120 |
Why?
|
| Cystatins | 2 | 2008 | 55 | 0.120 |
Why?
|
| Culicidae | 1 | 2015 | 110 | 0.120 |
Why?
|
| Risk Factors | 27 | 2018 | 74853 | 0.120 |
Why?
|
| Caspase 1 | 2 | 2015 | 227 | 0.120 |
Why?
|
| Caffeine | 1 | 2020 | 702 | 0.120 |
Why?
|
| Methionine | 2 | 2010 | 569 | 0.120 |
Why?
|
| Guidelines as Topic | 2 | 2018 | 1393 | 0.120 |
Why?
|
| Ubiquitination | 3 | 2020 | 996 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2021 | 6252 | 0.120 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1996 | 174 | 0.120 |
Why?
|
| Indoles | 4 | 2011 | 1832 | 0.120 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2009 | 422 | 0.120 |
Why?
|
| Metformin | 1 | 2022 | 904 | 0.120 |
Why?
|
| Energy Metabolism | 6 | 2020 | 2891 | 0.120 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 691 | 0.120 |
Why?
|
| Detergents | 4 | 2012 | 235 | 0.120 |
Why?
|
| Predictive Value of Tests | 16 | 2017 | 15398 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 3 | 2004 | 479 | 0.120 |
Why?
|
| Aminopyridines | 1 | 2018 | 576 | 0.120 |
Why?
|
| Cloning, Molecular | 3 | 2018 | 4165 | 0.120 |
Why?
|
| Chemokines | 1 | 1999 | 956 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 76 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2001 | 1497 | 0.120 |
Why?
|
| Maze Learning | 6 | 2016 | 482 | 0.120 |
Why?
|
| Protease Inhibitors | 3 | 2003 | 746 | 0.120 |
Why?
|
| Formates | 2 | 2021 | 37 | 0.120 |
Why?
|
| Chemotaxis | 2 | 2013 | 596 | 0.110 |
Why?
|
| Valine | 3 | 2010 | 410 | 0.110 |
Why?
|
| Proteins | 3 | 2006 | 5996 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 1118 | 0.110 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 1995 | 92 | 0.110 |
Why?
|
| Homocysteine | 2 | 2009 | 638 | 0.110 |
Why?
|
| Dermoscopy | 1 | 2014 | 73 | 0.110 |
Why?
|
| Motor Cortex | 1 | 2021 | 1003 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2016 | 332 | 0.110 |
Why?
|
| Infrared Rays | 3 | 2005 | 246 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 1997 | 700 | 0.110 |
Why?
|
| Mucolipidoses | 1 | 2014 | 82 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 433 | 0.110 |
Why?
|
| Peptidomimetics | 1 | 2013 | 30 | 0.110 |
Why?
|
| Malonates | 1 | 1993 | 43 | 0.110 |
Why?
|
| Autophagy | 2 | 2012 | 1352 | 0.110 |
Why?
|
| Cerebral Decortication | 1 | 1993 | 11 | 0.110 |
Why?
|
| Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
| Lipid Metabolism | 4 | 2019 | 1892 | 0.110 |
Why?
|
| United States | 16 | 2024 | 72896 | 0.110 |
Why?
|
| Acetylcysteine | 2 | 2015 | 262 | 0.110 |
Why?
|
| Uric Acid | 1 | 2020 | 808 | 0.110 |
Why?
|
| Prescription Drugs | 1 | 2021 | 634 | 0.110 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 1993 | 88 | 0.110 |
Why?
|
| Antioxidants | 4 | 2015 | 1670 | 0.110 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 12966 | 0.110 |
Why?
|
| Blindness | 1 | 2017 | 587 | 0.110 |
Why?
|
| Quinolines | 3 | 2011 | 770 | 0.110 |
Why?
|
| Sequence Deletion | 3 | 2015 | 1493 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2014 | 160 | 0.110 |
Why?
|
| Metabolomics | 1 | 2022 | 1668 | 0.110 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 1995 | 437 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2009 | 1024 | 0.110 |
Why?
|
| Tomography | 2 | 2013 | 443 | 0.100 |
Why?
|
| Genetic Variation | 5 | 2018 | 6607 | 0.100 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 369 | 0.100 |
Why?
|
| Enzyme Assays | 1 | 2014 | 102 | 0.100 |
Why?
|
| Eye | 1 | 2017 | 710 | 0.100 |
Why?
|
| Microdialysis | 1 | 2013 | 156 | 0.100 |
Why?
|
| Pancreatitis, Alcoholic | 1 | 2012 | 28 | 0.100 |
Why?
|
| Immunity | 1 | 2019 | 1002 | 0.100 |
Why?
|
| Chemistry, Clinical | 1 | 2013 | 64 | 0.100 |
Why?
|
| Peptides | 2 | 2024 | 4331 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1084 | 0.100 |
Why?
|
| Lipoproteins, LDL | 1 | 1996 | 643 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2013 | 6014 | 0.100 |
Why?
|
| Trypsinogen | 1 | 2012 | 84 | 0.100 |
Why?
|
| DNA Mutational Analysis | 6 | 2011 | 4110 | 0.100 |
Why?
|
| Surface Plasmon Resonance | 3 | 2008 | 268 | 0.100 |
Why?
|
| Cross-Sectional Studies | 14 | 2021 | 26276 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2018 | 1332 | 0.100 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 1746 | 0.100 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2012 | 297 | 0.100 |
Why?
|
| Feedback, Physiological | 3 | 2012 | 479 | 0.100 |
Why?
|
| Nerve Endings | 2 | 1992 | 103 | 0.100 |
Why?
|
| Plant Lectins | 1 | 1992 | 103 | 0.100 |
Why?
|
| Multiprotein Complexes | 3 | 2008 | 1108 | 0.100 |
Why?
|
| Trypsin Inhibitor, Kunitz Soybean | 1 | 1992 | 11 | 0.100 |
Why?
|
| Pyrroles | 1 | 2018 | 1119 | 0.100 |
Why?
|
| Eye Enucleation | 1 | 2012 | 128 | 0.100 |
Why?
|
| Herpesvirus 1, Human | 1 | 2018 | 743 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2427 | 0.100 |
Why?
|
| Enzyme Precursors | 2 | 2010 | 164 | 0.100 |
Why?
|
| Receptors, AMPA | 2 | 2012 | 334 | 0.100 |
Why?
|
| Geriatrics | 1 | 1996 | 394 | 0.100 |
Why?
|
| Quality Control | 2 | 2013 | 835 | 0.100 |
Why?
|
| Trypsin | 1 | 2012 | 487 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 4 | 2011 | 2649 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 118 | 0.100 |
Why?
|
| Octoxynol | 3 | 2006 | 76 | 0.100 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2009 | 262 | 0.100 |
Why?
|
| Wakefulness | 1 | 2019 | 1281 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 308 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 291 | 0.090 |
Why?
|
| Laboratories, Hospital | 1 | 2013 | 192 | 0.090 |
Why?
|
| Homeostasis | 3 | 2013 | 3335 | 0.090 |
Why?
|
| Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Eye Neoplasms | 3 | 1983 | 305 | 0.090 |
Why?
|
| Membrane Microdomains | 2 | 2010 | 203 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2021 | 2794 | 0.090 |
Why?
|
| Endothelial Cells | 3 | 2023 | 3584 | 0.090 |
Why?
|
| Gyrus Cinguli | 1 | 2017 | 1116 | 0.090 |
Why?
|
| Precipitin Tests | 5 | 2004 | 812 | 0.090 |
Why?
|
| Doxycycline | 2 | 2011 | 348 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 2 | 2020 | 2822 | 0.090 |
Why?
|
| Chemokine CCL4 | 3 | 2000 | 124 | 0.090 |
Why?
|
| Antigens | 3 | 1991 | 1438 | 0.090 |
Why?
|
| Microtomy | 1 | 2010 | 43 | 0.090 |
Why?
|
| COS Cells | 6 | 2014 | 1135 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 3 | 2018 | 431 | 0.090 |
Why?
|
| Macrolides | 1 | 2012 | 204 | 0.090 |
Why?
|
| Laser-Doppler Flowmetry | 2 | 2008 | 236 | 0.090 |
Why?
|
| Tyrosine 3-Monooxygenase | 5 | 2014 | 365 | 0.090 |
Why?
|
| Aphasia | 2 | 1990 | 192 | 0.090 |
Why?
|
| Retinoblastoma | 3 | 1983 | 316 | 0.090 |
Why?
|
| Fluoresceins | 1 | 2011 | 234 | 0.090 |
Why?
|
| Proteomics | 2 | 2021 | 3909 | 0.090 |
Why?
|
| Photobleaching | 1 | 2010 | 29 | 0.090 |
Why?
|
| Adult | 34 | 2024 | 223055 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2012 | 442 | 0.090 |
Why?
|
| Amygdala | 4 | 1992 | 1376 | 0.090 |
Why?
|
| Research Design | 3 | 2017 | 6207 | 0.090 |
Why?
|
| Drug Design | 3 | 2011 | 1040 | 0.090 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2010 | 35 | 0.090 |
Why?
|
| Mutant Proteins | 3 | 2018 | 485 | 0.090 |
Why?
|
| Molecular Imaging | 2 | 2014 | 822 | 0.090 |
Why?
|
| Radioisotopes | 1 | 2012 | 498 | 0.090 |
Why?
|
| Nevus, Pigmented | 1 | 1992 | 222 | 0.090 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2001 | 133 | 0.090 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 3851 | 0.080 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 286 | 0.080 |
Why?
|
| Virus Replication | 1 | 2018 | 2446 | 0.080 |
Why?
|
| Statistics as Topic | 3 | 2012 | 2350 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2011 | 198 | 0.080 |
Why?
|
| Glycoproteins | 3 | 2012 | 2195 | 0.080 |
Why?
|
| Sweden | 5 | 2015 | 1381 | 0.080 |
Why?
|
| Oligodendroglia | 1 | 2014 | 543 | 0.080 |
Why?
|
| Inflammasomes | 1 | 2015 | 544 | 0.080 |
Why?
|
| Propidium | 1 | 2009 | 42 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 280 | 0.080 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2210 | 0.080 |
Why?
|
| Salicylates | 1 | 2010 | 125 | 0.080 |
Why?
|
| Drug Repositioning | 2 | 2022 | 244 | 0.080 |
Why?
|
| DNA | 6 | 2022 | 7197 | 0.080 |
Why?
|
| Central Nervous System Agents | 1 | 2010 | 72 | 0.080 |
Why?
|
| Brain Mapping | 6 | 2016 | 6598 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 3 | 2004 | 474 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 2 | 2016 | 2010 | 0.080 |
Why?
|
| Host-Pathogen Interactions | 1 | 2018 | 1461 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2009 | 332 | 0.080 |
Why?
|
| Massachusetts | 4 | 2015 | 8875 | 0.080 |
Why?
|
| Cell Lineage | 1 | 2018 | 2573 | 0.080 |
Why?
|
| Optic Nerve | 1 | 2012 | 568 | 0.080 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 88 | 0.080 |
Why?
|
| Molecular Biology | 2 | 2007 | 574 | 0.080 |
Why?
|
| Glucose | 2 | 2016 | 4332 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2009 | 102 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2012 | 1213 | 0.080 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1027 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2017 | 2444 | 0.080 |
Why?
|
| Social Participation | 2 | 2021 | 187 | 0.080 |
Why?
|
| Serum Amyloid A Protein | 1 | 2009 | 127 | 0.080 |
Why?
|
| Benzoquinones | 2 | 2010 | 197 | 0.080 |
Why?
|
| Microscopy, Immunoelectron | 3 | 2016 | 315 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2013 | 550 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 4 | 2004 | 1139 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2012 | 413 | 0.080 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2008 | 128 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2022 | 4424 | 0.080 |
Why?
|
| Pyramidal Cells | 2 | 2004 | 365 | 0.070 |
Why?
|
| Environment | 2 | 2011 | 1116 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2007 | 114 | 0.070 |
Why?
|
| Hydrazines | 1 | 2009 | 223 | 0.070 |
Why?
|
| Kinetics | 9 | 2006 | 6272 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 200 | 0.070 |
Why?
|
| F2-Isoprostanes | 1 | 2007 | 35 | 0.070 |
Why?
|
| Neural Inhibition | 1 | 2012 | 589 | 0.070 |
Why?
|
| Protein Biosynthesis | 2 | 2009 | 2087 | 0.070 |
Why?
|
| Neurology | 1 | 1996 | 784 | 0.070 |
Why?
|
| Simvastatin | 1 | 2010 | 345 | 0.070 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2010 | 348 | 0.070 |
Why?
|
| Furans | 2 | 2007 | 198 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2000 | 450 | 0.070 |
Why?
|
| Nuclear Envelope | 1 | 2008 | 161 | 0.070 |
Why?
|
| Interview, Psychological | 1 | 2011 | 811 | 0.070 |
Why?
|
| Orthopedic Procedures | 1 | 2017 | 1279 | 0.070 |
Why?
|
| Microfluidics | 1 | 2013 | 651 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2015 | 869 | 0.070 |
Why?
|
| Histocytochemistry | 4 | 1998 | 695 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 818 | 0.070 |
Why?
|
| Sensation | 1 | 1989 | 331 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 366 | 0.070 |
Why?
|
| Encephalitis | 2 | 2021 | 440 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 2 | 2021 | 419 | 0.070 |
Why?
|
| Receptors, Angiotensin | 1 | 2007 | 141 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2009 | 780 | 0.070 |
Why?
|
| Lactams, Macrocyclic | 2 | 2010 | 318 | 0.070 |
Why?
|
| Leukotrienes | 1 | 2008 | 232 | 0.070 |
Why?
|
| Cerebellum | 5 | 2006 | 1519 | 0.070 |
Why?
|
| Lasers | 3 | 2006 | 951 | 0.070 |
Why?
|
| Neurofilament Proteins | 2 | 2021 | 336 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2017 | 3078 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2006 | 279 | 0.070 |
Why?
|
| Insulysin | 1 | 2007 | 49 | 0.070 |
Why?
|
| Oxidation-Reduction | 4 | 2005 | 2219 | 0.070 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2008 | 132 | 0.070 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2006 | 23 | 0.070 |
Why?
|
| Sensory Receptor Cells | 1 | 2012 | 510 | 0.070 |
Why?
|
| Myelin Sheath | 2 | 2014 | 652 | 0.070 |
Why?
|
| Heparitin Sulfate | 1 | 2008 | 223 | 0.070 |
Why?
|
| Genomics | 2 | 2022 | 5926 | 0.070 |
Why?
|
| Drosophila | 3 | 2021 | 1501 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 542 | 0.070 |
Why?
|
| Protein Kinases | 1 | 1994 | 1611 | 0.070 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2013 | 445 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2002 | 610 | 0.070 |
Why?
|
| Auxilins | 1 | 2006 | 29 | 0.070 |
Why?
|
| Macaca mulatta | 5 | 2004 | 2341 | 0.070 |
Why?
|
| t-Complex Genome Region | 1 | 2006 | 5 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2022 | 12235 | 0.070 |
Why?
|
| Acute Disease | 2 | 2012 | 7237 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2010 | 628 | 0.070 |
Why?
|
| Genetic Testing | 5 | 2019 | 3590 | 0.070 |
Why?
|
| MPTP Poisoning | 2 | 1998 | 36 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 443 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2014 | 684 | 0.060 |
Why?
|
| Curcumin | 1 | 2007 | 97 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2009 | 549 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2007 | 275 | 0.060 |
Why?
|
| Toes | 1 | 1987 | 209 | 0.060 |
Why?
|
| Glutamates | 1 | 1987 | 384 | 0.060 |
Why?
|
| LDL-Receptor Related Protein-Associated Protein | 2 | 2004 | 17 | 0.060 |
Why?
|
| Regression Analysis | 4 | 2015 | 6320 | 0.060 |
Why?
|
| Mammals | 2 | 2021 | 1125 | 0.060 |
Why?
|
| Delirium | 1 | 2017 | 1698 | 0.060 |
Why?
|
| Escherichia coli | 1 | 2018 | 4211 | 0.060 |
Why?
|
| Luminescent Agents | 1 | 2005 | 30 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 85 | 0.060 |
Why?
|
| Injections, Intraperitoneal | 5 | 2002 | 411 | 0.060 |
Why?
|
| Linear Models | 4 | 2017 | 5873 | 0.060 |
Why?
|
| Patient Care | 1 | 2011 | 629 | 0.060 |
Why?
|
| Half-Life | 1 | 2006 | 645 | 0.060 |
Why?
|
| Peptide Hydrolases | 2 | 2009 | 607 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2021 | 8532 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2010 | 3418 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2008 | 711 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 884 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 1525 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2004 | 285 | 0.060 |
Why?
|
| Resilience, Psychological | 1 | 2013 | 808 | 0.060 |
Why?
|
| Glaucoma | 2 | 2017 | 1194 | 0.060 |
Why?
|
| Kidney | 5 | 2006 | 7073 | 0.060 |
Why?
|
| Computational Biology | 3 | 2024 | 3557 | 0.060 |
Why?
|
| Biophysics | 3 | 2003 | 375 | 0.060 |
Why?
|
| Meninges | 3 | 2006 | 201 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1409 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 991 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2009 | 833 | 0.060 |
Why?
|
| Sex Characteristics | 2 | 2019 | 2643 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 2 | 1997 | 419 | 0.060 |
Why?
|
| Polyneuropathies | 1 | 1986 | 139 | 0.060 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2024 | 9 | 0.060 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 276 | 0.060 |
Why?
|
| Anterior Horn Cells | 1 | 2004 | 18 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2009 | 1092 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2012 | 2741 | 0.060 |
Why?
|
| Steroid Hydroxylases | 1 | 2004 | 93 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2007 | 844 | 0.060 |
Why?
|
| Sirtuins | 1 | 2007 | 322 | 0.060 |
Why?
|
| Prostaglandins | 2 | 1982 | 396 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2005 | 1750 | 0.060 |
Why?
|
| Substance P | 3 | 1994 | 331 | 0.060 |
Why?
|
| Education, Medical | 1 | 1996 | 1746 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1349 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 457 | 0.060 |
Why?
|
| Phagocytosis | 2 | 2016 | 1518 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2844 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2006 | 832 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 899 | 0.060 |
Why?
|
| Leukotriene C4 | 1 | 2004 | 79 | 0.060 |
Why?
|
| Annexins | 1 | 2003 | 39 | 0.060 |
Why?
|
| Annexin A1 | 1 | 2003 | 22 | 0.060 |
Why?
|
| Motor Neuron Disease | 1 | 2004 | 98 | 0.050 |
Why?
|
| Sarcolemma | 1 | 2003 | 66 | 0.050 |
Why?
|
| Embolism | 1 | 1987 | 403 | 0.050 |
Why?
|
| Stathmin | 1 | 2024 | 68 | 0.050 |
Why?
|
| Drug Administration Routes | 1 | 2003 | 152 | 0.050 |
Why?
|
| Threonine | 1 | 2004 | 272 | 0.050 |
Why?
|
| Annexin A2 | 1 | 2003 | 43 | 0.050 |
Why?
|
| Denervation | 2 | 1995 | 265 | 0.050 |
Why?
|
| Mass Spectrometry | 3 | 2021 | 2194 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2017 | 5089 | 0.050 |
Why?
|
| Glycosylation | 1 | 2006 | 1099 | 0.050 |
Why?
|
| Choline | 2 | 2002 | 511 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2003 | 323 | 0.050 |
Why?
|
| Putamen | 1 | 2024 | 289 | 0.050 |
Why?
|
| Radioligand Assay | 3 | 2017 | 364 | 0.050 |
Why?
|
| Somatostatin | 3 | 1994 | 459 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2005 | 1226 | 0.050 |
Why?
|
| Solitary Nucleus | 1 | 2023 | 54 | 0.050 |
Why?
|
| Naltrexone | 1 | 1985 | 319 | 0.050 |
Why?
|
| Receptors, IgG | 1 | 2006 | 559 | 0.050 |
Why?
|
| Prognosis | 6 | 2023 | 29915 | 0.050 |
Why?
|
| Sleep | 1 | 2019 | 4819 | 0.050 |
Why?
|
| Protein Stability | 2 | 2018 | 576 | 0.050 |
Why?
|
| Acetylation | 2 | 2021 | 1056 | 0.050 |
Why?
|
| Rhodamines | 1 | 2003 | 178 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 5786 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2002 | 1056 | 0.050 |
Why?
|
| Proportional Hazards Models | 6 | 2017 | 12520 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2024 | 388 | 0.050 |
Why?
|
| Fluorescein | 1 | 2003 | 175 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 1986 | 350 | 0.050 |
Why?
|
| Action Potentials | 2 | 2019 | 1837 | 0.050 |
Why?
|
| Dentate Gyrus | 2 | 2021 | 165 | 0.050 |
Why?
|
| Cadaver | 2 | 2015 | 1362 | 0.050 |
Why?
|
| Cytosol | 1 | 2006 | 885 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2022 | 3677 | 0.050 |
Why?
|
| Dissection | 1 | 2024 | 299 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 415 | 0.050 |
Why?
|
| Swine, Miniature | 1 | 2024 | 972 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2003 | 572 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2009 | 2667 | 0.050 |
Why?
|
| Syndrome | 4 | 2003 | 3269 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 1992 | 2629 | 0.050 |
Why?
|
| RNA Interference | 3 | 2009 | 2827 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2002 | 152 | 0.050 |
Why?
|
| Immunization | 1 | 2006 | 1218 | 0.050 |
Why?
|
| Odds Ratio | 4 | 2017 | 9653 | 0.050 |
Why?
|
| Receptors, CCR3 | 2 | 1998 | 61 | 0.050 |
Why?
|
| Animals, Newborn | 5 | 2006 | 2670 | 0.050 |
Why?
|
| Prefrontal Cortex | 2 | 2023 | 2223 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1405 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2008 | 1870 | 0.050 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2001 | 28 | 0.050 |
Why?
|
| Quinolinic Acids | 2 | 1991 | 15 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2023 | 303 | 0.050 |
Why?
|
| DNA, Recombinant | 2 | 2006 | 455 | 0.050 |
Why?
|
| Chemokine CXCL1 | 1 | 2002 | 102 | 0.050 |
Why?
|
| Models, Biological | 7 | 2012 | 9441 | 0.050 |
Why?
|
| Telomere | 1 | 2008 | 941 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2002 | 110 | 0.050 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 1981 | 65 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2018 | 6872 | 0.050 |
Why?
|
| Organ Size | 3 | 2017 | 2260 | 0.050 |
Why?
|
| Proxy | 1 | 2022 | 150 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2007 | 975 | 0.050 |
Why?
|
| Vasodilation | 2 | 2007 | 970 | 0.050 |
Why?
|
| Trypsin Inhibitors | 1 | 2001 | 32 | 0.050 |
Why?
|
| Adamantane | 1 | 2022 | 148 | 0.050 |
Why?
|
| Peroxidase | 1 | 2004 | 604 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 543 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2023 | 354 | 0.050 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12056 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2021 | 74 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2012 | 9355 | 0.050 |
Why?
|
| Photography | 1 | 2024 | 535 | 0.050 |
Why?
|
| Thiophenes | 1 | 2005 | 570 | 0.050 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 411 | 0.050 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 3 | 1998 | 60 | 0.050 |
Why?
|
| Iron | 1 | 2009 | 1814 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2022 | 220 | 0.050 |
Why?
|
| Homovanillic Acid | 3 | 1998 | 73 | 0.050 |
Why?
|
| Leupeptins | 1 | 2001 | 112 | 0.050 |
Why?
|
| Isoleucine | 2 | 1998 | 109 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1083 | 0.050 |
Why?
|
| Personal Autonomy | 1 | 2023 | 316 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10428 | 0.040 |
Why?
|
| Dextrans | 1 | 2003 | 570 | 0.040 |
Why?
|
| Phospholipids | 5 | 1983 | 776 | 0.040 |
Why?
|
| Nitroprusside | 1 | 2001 | 271 | 0.040 |
Why?
|
| Ligases | 1 | 2002 | 330 | 0.040 |
Why?
|
| Brain Ischemia | 2 | 2008 | 3001 | 0.040 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 2741 | 0.040 |
Why?
|
| Protein Subunits | 3 | 2009 | 939 | 0.040 |
Why?
|
| Dipeptides | 1 | 2002 | 386 | 0.040 |
Why?
|
| Lactates | 4 | 1994 | 398 | 0.040 |
Why?
|
| Nitrates | 1 | 2002 | 260 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2006 | 614 | 0.040 |
Why?
|
| Administration, Topical | 1 | 2002 | 703 | 0.040 |
Why?
|
| Receptors, Notch | 3 | 2004 | 752 | 0.040 |
Why?
|
| Terminology as Topic | 3 | 2014 | 1536 | 0.040 |
Why?
|
| Vitamins | 1 | 2009 | 1631 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 2020 | 913 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2000 | 137 | 0.040 |
Why?
|
| Stroke | 2 | 2015 | 9749 | 0.040 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2006 | 1166 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 2971 | 0.040 |
Why?
|
| Prospective Studies | 9 | 2017 | 54798 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2002 | 332 | 0.040 |
Why?
|
| Cerebral Infarction | 2 | 2002 | 969 | 0.040 |
Why?
|
| Nitriles | 1 | 2005 | 983 | 0.040 |
Why?
|
| Basal Ganglia Diseases | 2 | 2017 | 145 | 0.040 |
Why?
|
| Receptors, Scavenger | 2 | 2001 | 123 | 0.040 |
Why?
|
| Tritium | 2 | 2017 | 702 | 0.040 |
Why?
|
| Hypercholesterolemia | 2 | 2010 | 1148 | 0.040 |
Why?
|
| Catalytic Domain | 2 | 2013 | 699 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2011 | 1967 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2002 | 562 | 0.040 |
Why?
|
| Least-Squares Analysis | 2 | 2015 | 368 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2021 | 292 | 0.040 |
Why?
|
| Mice, Inbred DBA | 1 | 2001 | 624 | 0.040 |
Why?
|
| Cryoprotective Agents | 1 | 2001 | 123 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2001 | 250 | 0.040 |
Why?
|
| Cyclic N-Oxides | 3 | 2009 | 71 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2001 | 241 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2008 | 2761 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2004 | 1202 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2006 | 1505 | 0.040 |
Why?
|
| Anesthesia | 1 | 2010 | 1581 | 0.040 |
Why?
|
| Biological Transport | 4 | 2016 | 2082 | 0.040 |
Why?
|
| Nucleotides | 1 | 2022 | 451 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 834 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2022 | 483 | 0.040 |
Why?
|
| Spinal Cord Ischemia | 1 | 2000 | 94 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2017 | 81505 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2000 | 240 | 0.040 |
Why?
|
| Fatty Acids | 3 | 1981 | 1806 | 0.040 |
Why?
|
| Fetus | 3 | 2002 | 1878 | 0.040 |
Why?
|
| Decision Making | 2 | 2023 | 3955 | 0.040 |
Why?
|
| RNA Splicing | 1 | 2024 | 904 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2000 | 310 | 0.040 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2019 | 87 | 0.040 |
Why?
|
| Acids | 1 | 1999 | 125 | 0.040 |
Why?
|
| Carcinoma | 1 | 2010 | 2312 | 0.040 |
Why?
|
| Frontal Lobe | 3 | 2008 | 1409 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 5995 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2006 | 2141 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2004 | 1736 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2016 | 5302 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 752 | 0.040 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 39226 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2014 | 4618 | 0.040 |
Why?
|
| Oxygen | 2 | 2008 | 4242 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2024 | 869 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2001 | 626 | 0.040 |
Why?
|
| Retina | 2 | 1997 | 2648 | 0.040 |
Why?
|
| Warfarin | 1 | 1987 | 1494 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2014 | 533 | 0.040 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 84 | 0.040 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 1324 | 0.040 |
Why?
|
| Neurocytoma | 1 | 1998 | 28 | 0.040 |
Why?
|
| Densitometry | 1 | 1998 | 150 | 0.040 |
Why?
|
| Goals | 1 | 2024 | 717 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1998 | 68 | 0.040 |
Why?
|
| Rabbits | 2 | 2002 | 4731 | 0.040 |
Why?
|
| Equipment Design | 1 | 2006 | 3488 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15794 | 0.040 |
Why?
|
| Ginkgo biloba | 2 | 2009 | 26 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2003 | 1160 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1048 | 0.040 |
Why?
|
| Cytoskeleton | 2 | 2017 | 1178 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 3815 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 687 | 0.040 |
Why?
|
| Logistic Models | 6 | 2008 | 13266 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 714 | 0.040 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1998 | 71 | 0.040 |
Why?
|
| Sequence Alignment | 4 | 2009 | 2171 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2017 | 54 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 3435 | 0.040 |
Why?
|
| Probability | 2 | 2020 | 2475 | 0.040 |
Why?
|
| Cations | 1 | 2018 | 239 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 1770 | 0.040 |
Why?
|
| Sex Factors | 3 | 2020 | 10607 | 0.040 |
Why?
|
| Bioethics | 1 | 2019 | 118 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2020 | 947 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2018 | 250 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2018 | 521 | 0.040 |
Why?
|
| Choice Behavior | 1 | 2023 | 846 | 0.040 |
Why?
|
| Rodentia | 1 | 1999 | 262 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1997 | 141 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2000 | 685 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2014 | 565 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2001 | 4422 | 0.030 |
Why?
|
| Medical Records | 1 | 2022 | 1409 | 0.030 |
Why?
|
| Flavonoids | 2 | 2014 | 446 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2015 | 416 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 2002 | 873 | 0.030 |
Why?
|
| Feedback | 1 | 2001 | 796 | 0.030 |
Why?
|
| Iowa | 1 | 1996 | 100 | 0.030 |
Why?
|
| Serotyping | 2 | 2009 | 330 | 0.030 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.030 |
Why?
|
| 5-Lipoxygenase-Activating Proteins | 2 | 2008 | 24 | 0.030 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 1997 | 168 | 0.030 |
Why?
|
| Allosteric Regulation | 2 | 2013 | 425 | 0.030 |
Why?
|
| Nitro Compounds | 2 | 1993 | 74 | 0.030 |
Why?
|
| Independent Living | 1 | 2021 | 584 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 9069 | 0.030 |
Why?
|
| Transcytosis | 1 | 2016 | 48 | 0.030 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2009 | 107 | 0.030 |
Why?
|
| Glutamic Acid | 2 | 1996 | 1180 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2021 | 682 | 0.030 |
Why?
|
| Coculture Techniques | 2 | 2010 | 1336 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2001 | 988 | 0.030 |
Why?
|
| Risperidone | 1 | 1999 | 383 | 0.030 |
Why?
|
| Long-Term Potentiation | 2 | 2013 | 290 | 0.030 |
Why?
|
| Complement C1q | 1 | 2016 | 82 | 0.030 |
Why?
|
| Serotonin | 1 | 2021 | 1047 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1997 | 821 | 0.030 |
Why?
|
| Linkage Disequilibrium | 2 | 2017 | 1996 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1999 | 855 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2001 | 1788 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2001 | 997 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2003 | 1306 | 0.030 |
Why?
|
| Cell Size | 1 | 1998 | 626 | 0.030 |
Why?
|
| Neuropeptide Y | 2 | 1994 | 194 | 0.030 |
Why?
|
| Rats, Inbred Strains | 6 | 1992 | 2077 | 0.030 |
Why?
|
| Tropanes | 1 | 2015 | 47 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2015 | 40 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2016 | 322 | 0.030 |
Why?
|
| Pedigree | 3 | 2015 | 4528 | 0.030 |
Why?
|
| Memantine | 1 | 1996 | 110 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1999 | 743 | 0.030 |
Why?
|
| Piperazines | 1 | 2006 | 2546 | 0.030 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 15645 | 0.030 |
Why?
|
| Free Radical Scavengers | 2 | 2009 | 213 | 0.030 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2018 | 541 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 1997 | 608 | 0.030 |
Why?
|
| Glucose Transporter Type 3 | 1 | 1995 | 16 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1997 | 334 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 938 | 0.030 |
Why?
|
| Adenosine Triphosphate | 4 | 1994 | 1999 | 0.030 |
Why?
|
| Argentina | 1 | 2015 | 249 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.030 |
Why?
|
| Biogenic Amines | 1 | 1994 | 53 | 0.030 |
Why?
|
| Reaction Time | 1 | 2001 | 2086 | 0.030 |
Why?
|
| Lameness, Animal | 1 | 2014 | 7 | 0.030 |
Why?
|
| Tooth Diseases | 1 | 1995 | 73 | 0.030 |
Why?
|
| Estrogens | 1 | 2001 | 1527 | 0.030 |
Why?
|
| Organ Specificity | 3 | 1996 | 1964 | 0.030 |
Why?
|
| Particle Size | 1 | 1999 | 1632 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2018 | 1884 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2024 | 2393 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5986 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 84 | 0.030 |
Why?
|
| Visual Perception | 1 | 2003 | 1394 | 0.030 |
Why?
|
| Prevalence | 3 | 2016 | 15832 | 0.030 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2014 | 63 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3592 | 0.030 |
Why?
|
| Azides | 1 | 1994 | 120 | 0.030 |
Why?
|
| Pathology | 1 | 1997 | 270 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 2879 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 151 | 0.030 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 800 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 169 | 0.030 |
Why?
|
| Vitamin B 12 | 2 | 2009 | 531 | 0.030 |
Why?
|
| Alanine | 2 | 2009 | 613 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 1995 | 138 | 0.030 |
Why?
|
| Plant Extracts | 2 | 2009 | 498 | 0.030 |
Why?
|
| Drosophila melanogaster | 3 | 2009 | 1721 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 398 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2014 | 247 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 2 | 1994 | 1606 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 510 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2010 | 3794 | 0.030 |
Why?
|
| Melanoma | 1 | 1992 | 5696 | 0.030 |
Why?
|
| Lactic Acid | 3 | 1993 | 1137 | 0.030 |
Why?
|
| Cystatin C | 2 | 2008 | 272 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1998 | 772 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 182 | 0.030 |
Why?
|
| Mitosis | 1 | 1999 | 1175 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2015 | 302 | 0.030 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 130 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1996 | 674 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2010 | 1132 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 1995 | 472 | 0.030 |
Why?
|
| Natural Language Processing | 1 | 2022 | 1198 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1697 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 271 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1994 | 209 | 0.030 |
Why?
|
| Disulfides | 1 | 2015 | 462 | 0.030 |
Why?
|
| Pyridines | 3 | 2015 | 2887 | 0.030 |
Why?
|
| Trigeminal Ganglion | 1 | 1994 | 189 | 0.030 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2013 | 139 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 412 | 0.030 |
Why?
|
| Eating | 1 | 2020 | 1538 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2538 | 0.030 |
Why?
|
| Space Perception | 2 | 2011 | 469 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 5837 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3427 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 284 | 0.030 |
Why?
|
| Electron Transport | 1 | 1993 | 210 | 0.030 |
Why?
|
| Afferent Pathways | 1 | 1993 | 303 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 752 | 0.020 |
Why?
|
| Wound Healing | 1 | 2003 | 2792 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2000 | 1786 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2878 | 0.020 |
Why?
|
| Trypan Blue | 1 | 2011 | 20 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2014 | 228 | 0.020 |
Why?
|
| Aminooxyacetic Acid | 1 | 1991 | 7 | 0.020 |
Why?
|
| Organelle Size | 1 | 2011 | 6 | 0.020 |
Why?
|
| Hypercalcemia | 1 | 1995 | 425 | 0.020 |
Why?
|
| Molecular Structure | 2 | 2007 | 1886 | 0.020 |
Why?
|
| Japan | 1 | 1996 | 1415 | 0.020 |
Why?
|
| Cerebrovascular Trauma | 1 | 2011 | 21 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2018 | 3612 | 0.020 |
Why?
|
| Internet | 1 | 2024 | 3104 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2004 | 1545 | 0.020 |
Why?
|
| Ecosystem | 1 | 2015 | 489 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 1994 | 496 | 0.020 |
Why?
|
| Drug Interactions | 2 | 2007 | 1416 | 0.020 |
Why?
|
| Quisqualic Acid | 1 | 1991 | 35 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 160 | 0.020 |
Why?
|
| RNA | 2 | 2012 | 2716 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 211 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 1984 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 2008 | 2097 | 0.020 |
Why?
|
| Macrophages | 1 | 2006 | 5771 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1994 | 634 | 0.020 |
Why?
|
| Risk | 3 | 2014 | 9600 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2013 | 186 | 0.020 |
Why?
|
| Causality | 2 | 2008 | 1247 | 0.020 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2011 | 183 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2012 | 391 | 0.020 |
Why?
|
| Free Radicals | 2 | 2003 | 238 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 2010 | 23 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2012 | 197 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1600 | 0.020 |
Why?
|
| Lipoid Proteinosis of Urbach and Wiethe | 1 | 1990 | 4 | 0.020 |
Why?
|
| Reperfusion | 2 | 2002 | 267 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 191 | 0.020 |
Why?
|
| Lectins | 1 | 1992 | 487 | 0.020 |
Why?
|
| Folic Acid | 2 | 2009 | 1337 | 0.020 |
Why?
|
| Stilbamidines | 1 | 2010 | 45 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 602 | 0.020 |
Why?
|
| Nitrogen Oxides | 2 | 2003 | 128 | 0.020 |
Why?
|
| Xanthenes | 1 | 2010 | 71 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2003 | 10262 | 0.020 |
Why?
|
| Olfactory Mucosa | 1 | 1991 | 101 | 0.020 |
Why?
|
| Injections | 1 | 1993 | 839 | 0.020 |
Why?
|
| Rats, Inbred BN | 1 | 2010 | 229 | 0.020 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2002 | 70 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2011 | 305 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2022 | 3107 | 0.020 |
Why?
|
| Cathelicidins | 1 | 2010 | 81 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 1992 | 249 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 810 | 0.020 |
Why?
|
| Ribosomes | 1 | 1993 | 494 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 380 | 0.020 |
Why?
|
| Psychophysiology | 1 | 1990 | 136 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2009 | 4018 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1001 | 0.020 |
Why?
|
| Thalamic Nuclei | 1 | 1990 | 113 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2011 | 2074 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 1996 | 1811 | 0.020 |
Why?
|
| Phagosomes | 1 | 2011 | 193 | 0.020 |
Why?
|
| Integrin alpha3beta1 | 1 | 2009 | 53 | 0.020 |
Why?
|
| Genes | 1 | 1993 | 1824 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2006 | 3088 | 0.020 |
Why?
|
| Allosteric Site | 1 | 2009 | 106 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 71 | 0.020 |
Why?
|
| Learning | 1 | 1999 | 1754 | 0.020 |
Why?
|
| Neurosurgery | 1 | 1996 | 682 | 0.020 |
Why?
|
| Trichothecenes | 1 | 2008 | 6 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1187 | 0.020 |
Why?
|
| Capillaries | 1 | 1992 | 751 | 0.020 |
Why?
|
| Neurochemistry | 1 | 1989 | 29 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 858 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 388 | 0.020 |
Why?
|
| ROC Curve | 2 | 2012 | 3617 | 0.020 |
Why?
|
| Musculoskeletal Diseases | 1 | 1995 | 598 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2008 | 148 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2010 | 277 | 0.020 |
Why?
|
| Intracellular Membranes | 2 | 2001 | 386 | 0.020 |
Why?
|
| Chromans | 1 | 2009 | 116 | 0.020 |
Why?
|
| Face | 1 | 1995 | 1028 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2008 | 107 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2008 | 69 | 0.020 |
Why?
|
| Syndecan-3 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Pyridoxine | 1 | 2009 | 108 | 0.020 |
Why?
|
| Monocytes | 1 | 1998 | 2592 | 0.020 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2008 | 108 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2009 | 317 | 0.020 |
Why?
|
| Metals | 1 | 2013 | 710 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2004 | 6274 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 368 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2009 | 274 | 0.020 |
Why?
|
| Calibration | 1 | 2011 | 814 | 0.020 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2008 | 34 | 0.020 |
Why?
|
| Glypicans | 1 | 2008 | 33 | 0.020 |
Why?
|
| Multiple Myeloma | 1 | 1986 | 5196 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2012 | 1639 | 0.020 |
Why?
|
| Neuropsychology | 1 | 1989 | 110 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 562 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2009 | 655 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 1991 | 564 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2007 | 61 | 0.020 |
Why?
|
| Oxazines | 1 | 2010 | 358 | 0.020 |
Why?
|
| K562 Cells | 1 | 2009 | 648 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 894 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1991 | 900 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 576 | 0.020 |
Why?
|
| Heat-Shock Proteins, Small | 1 | 2006 | 5 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2007 | 65 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 335 | 0.020 |
Why?
|
| Sirtuin 2 | 1 | 2007 | 93 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1747 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 601 | 0.020 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 126 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 377 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2007 | 153 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 355 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2008 | 209 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2000 | 42478 | 0.020 |
Why?
|
| Vibrissae | 1 | 2007 | 121 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2006 | 67 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2009 | 299 | 0.020 |
Why?
|
| Coated Pits, Cell-Membrane | 1 | 2006 | 74 | 0.020 |
Why?
|
| Gadolinium | 1 | 2011 | 966 | 0.020 |
Why?
|
| Systems Integration | 1 | 2008 | 425 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 238 | 0.020 |
Why?
|
| Myeloma Proteins | 1 | 1986 | 71 | 0.020 |
Why?
|
| Skin Window Technique | 1 | 2006 | 22 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 842 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 12 | 2 | 1998 | 432 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Color | 1 | 1987 | 299 | 0.020 |
Why?
|
| Hyperemia | 1 | 2007 | 224 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 1527 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2007 | 246 | 0.020 |
Why?
|
| Hypercapnia | 1 | 2007 | 259 | 0.020 |
Why?
|
| Physical Stimulation | 1 | 2007 | 513 | 0.020 |
Why?
|
| Losartan | 1 | 2007 | 263 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 364 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1986 | 171 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2005 | 53 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1999 | 3076 | 0.020 |
Why?
|
| Receptors, Opioid | 1 | 1985 | 144 | 0.020 |
Why?
|
| Clathrin | 1 | 2006 | 259 | 0.020 |
Why?
|
| Catalysis | 1 | 2007 | 770 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 1986 | 290 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1991 | 933 | 0.010 |
Why?
|
| Succinimides | 1 | 2005 | 83 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2017 | 10087 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2022 | 4864 | 0.010 |
Why?
|
| Phosphoamino Acids | 1 | 2004 | 6 | 0.010 |
Why?
|
| Levodopa | 1 | 2005 | 221 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 1945 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3503 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 2006 | 508 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2006 | 616 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2007 | 594 | 0.010 |
Why?
|
| Motor Activity | 1 | 2014 | 2705 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 4350 | 0.010 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 112 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6816 | 0.010 |
Why?
|
| Tomography, Optical | 1 | 2005 | 129 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 1993 | 2143 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1751 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2005 | 642 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2010 | 1304 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1376 | 0.010 |
Why?
|
| Chloroquine | 1 | 2005 | 275 | 0.010 |
Why?
|
| Immunoglobulin G | 3 | 2005 | 4526 | 0.010 |
Why?
|
| Aminoisobutyric Acids | 1 | 2003 | 39 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 653 | 0.010 |
Why?
|
| Esters | 1 | 2005 | 214 | 0.010 |
Why?
|
| Length of Stay | 1 | 2017 | 6485 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1987 | 1481 | 0.010 |
Why?
|
| Integrases | 1 | 2006 | 520 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 770 | 0.010 |
Why?
|
| Paraproteinemias | 1 | 1986 | 251 | 0.010 |
Why?
|
| Fluorescence Polarization | 1 | 2003 | 140 | 0.010 |
Why?
|
| Registries | 1 | 1999 | 8320 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2008 | 698 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2010 | 1971 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9336 | 0.010 |
Why?
|
| Adolescent | 5 | 2000 | 88794 | 0.010 |
Why?
|
| Arthritis | 1 | 2008 | 676 | 0.010 |
Why?
|
| Capsid | 1 | 2006 | 435 | 0.010 |
Why?
|
| Prostaglandins F | 1 | 1982 | 79 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2009 | 12421 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2010 | 970 | 0.010 |
Why?
|
| Cell Division | 2 | 1981 | 4471 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21064 | 0.010 |
Why?
|
| Molecular Motor Proteins | 1 | 2003 | 105 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1982 | 166 | 0.010 |
Why?
|
| Calcimycin | 1 | 1982 | 214 | 0.010 |
Why?
|
| Thalamus | 1 | 1989 | 1048 | 0.010 |
Why?
|
| Child | 4 | 2000 | 80509 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 1987 | 1063 | 0.010 |
Why?
|
| Demyelinating Diseases | 1 | 2005 | 355 | 0.010 |
Why?
|
| Psychomotor Performance | 2 | 2002 | 1883 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2003 | 613 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 765 | 0.010 |
Why?
|
| Students, Medical | 1 | 1996 | 1962 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2009 | 2655 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2006 | 897 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 562 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 2002 | 88 | 0.010 |
Why?
|
| Vitamin E | 1 | 2006 | 870 | 0.010 |
Why?
|
| Arachidonic Acids | 1 | 1982 | 293 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 2002 | 152 | 0.010 |
Why?
|
| Fear | 1 | 2011 | 1496 | 0.010 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2002 | 39 | 0.010 |
Why?
|
| Trachea | 1 | 1988 | 1086 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2014 | 3464 | 0.010 |
Why?
|
| Family Health | 1 | 2007 | 1253 | 0.010 |
Why?
|
| Microsomes | 1 | 1982 | 252 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2017 | 24278 | 0.010 |
Why?
|
| Diet, Atherogenic | 1 | 1981 | 91 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 2002 | 483 | 0.010 |
Why?
|
| Ouabain | 1 | 1982 | 246 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 1992 | 4883 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 696 | 0.010 |
Why?
|
| Heymann Nephritis Antigenic Complex | 1 | 2001 | 15 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 1981 | 150 | 0.010 |
Why?
|
| Cerebellar Cortex | 1 | 2002 | 108 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 2002 | 229 | 0.010 |
Why?
|
| Movement | 1 | 2008 | 1460 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 1981 | 68 | 0.010 |
Why?
|
| Glycerides | 1 | 1981 | 67 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3824 | 0.010 |
Why?
|
| Quinolinic Acid | 2 | 1991 | 67 | 0.010 |
Why?
|
| Imidazoles | 1 | 2007 | 1164 | 0.010 |
Why?
|
| Heparin | 1 | 2009 | 1631 | 0.010 |
Why?
|
| Temperature | 1 | 2008 | 2226 | 0.010 |
Why?
|
| Cholinesterases | 1 | 2001 | 32 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2001 | 244 | 0.010 |
Why?
|
| Middle Cerebral Artery | 1 | 2002 | 268 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1982 | 430 | 0.010 |
Why?
|
| Corpus Callosum | 1 | 2006 | 751 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2001 | 177 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 123 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 428 | 0.010 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2001 | 106 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1145 | 0.010 |
Why?
|
| HIV-1 | 1 | 1998 | 6943 | 0.010 |
Why?
|
| rab5 GTP-Binding Proteins | 1 | 2000 | 47 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 2001 | 156 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2005 | 4772 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 497 | 0.010 |
Why?
|
| Creatine | 1 | 2002 | 424 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2000 | 184 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2008 | 1726 | 0.010 |
Why?
|
| Vitamin A | 1 | 2003 | 610 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2000 | 198 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2001 | 291 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2005 | 750 | 0.010 |
Why?
|
| Gelsolin | 1 | 2000 | 189 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2004 | 674 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 1916 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3832 | 0.010 |
Why?
|
| Leukocytes | 1 | 2008 | 2027 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1982 | 591 | 0.010 |
Why?
|
| Observer Variation | 1 | 2006 | 2611 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 311 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1981 | 393 | 0.010 |
Why?
|
| Fatty Acids, Essential | 1 | 1980 | 97 | 0.010 |
Why?
|
| Macaca fascicularis | 1 | 1981 | 907 | 0.010 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2001 | 187 | 0.010 |
Why?
|
| Glycine | 1 | 1983 | 671 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 65223 | 0.010 |
Why?
|
| Mazindol | 1 | 1998 | 13 | 0.010 |
Why?
|
| Caspase 2 | 1 | 1998 | 26 | 0.010 |
Why?
|
| NAD | 1 | 2003 | 618 | 0.010 |
Why?
|
| Isomerism | 1 | 1999 | 197 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2007 | 2601 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2007 | 3160 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1990 | 5501 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2006 | 1798 | 0.010 |
Why?
|
| Fractals | 1 | 1999 | 124 | 0.010 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1999 | 323 | 0.010 |
Why?
|
| Transferrin | 1 | 1999 | 283 | 0.010 |
Why?
|
| Contrast Media | 1 | 2011 | 5329 | 0.010 |
Why?
|
| Radiography | 2 | 2005 | 6941 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2007 | 2027 | 0.010 |
Why?
|
| Encephalitis, Viral | 1 | 1998 | 59 | 0.010 |
Why?
|
| Lod Score | 1 | 1998 | 598 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2002 | 1166 | 0.010 |
Why?
|
| Electromyography | 1 | 2003 | 1399 | 0.010 |
Why?
|
| Hydroxyl Radical | 1 | 1997 | 82 | 0.010 |
Why?
|
| Maleic Anhydrides | 1 | 1977 | 8 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1986 | 1082 | 0.010 |
Why?
|
| Diffusion | 1 | 1999 | 808 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2008 | 6839 | 0.010 |
Why?
|
| Chemokine CCL5 | 1 | 1998 | 213 | 0.010 |
Why?
|
| Kainic Acid | 1 | 1997 | 204 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1999 | 608 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 1998 | 214 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 261 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 238 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 1998 | 287 | 0.010 |
Why?
|
| Retinal Artery Occlusion | 1 | 1997 | 82 | 0.010 |
Why?
|
| Coenzymes | 1 | 1997 | 101 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1999 | 698 | 0.010 |
Why?
|
| Triglycerides | 1 | 2004 | 2441 | 0.010 |
Why?
|
| Remission Induction | 1 | 2002 | 2410 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1990 | 4779 | 0.010 |
Why?
|
| Surface Properties | 1 | 1999 | 1153 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1977 | 318 | 0.010 |
Why?
|
| Ions | 1 | 1997 | 255 | 0.010 |
Why?
|
| Reference Standards | 1 | 1999 | 1013 | 0.010 |
Why?
|
| Neutrophils | 1 | 2008 | 3770 | 0.010 |
Why?
|
| Virion | 1 | 1998 | 428 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 1977 | 265 | 0.010 |
Why?
|
| Liposomes | 1 | 1980 | 787 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1999 | 1028 | 0.010 |
Why?
|
| Cell Separation | 1 | 2001 | 1718 | 0.010 |
Why?
|
| Ubiquinone | 1 | 1997 | 181 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1996 | 228 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1998 | 957 | 0.010 |
Why?
|
| Spin Labels | 1 | 1997 | 334 | 0.010 |
Why?
|
| Antiparkinson Agents | 1 | 1996 | 185 | 0.010 |
Why?
|
| Aprotinin | 1 | 1995 | 93 | 0.010 |
Why?
|
| Sodium Azide | 1 | 1994 | 24 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2617 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2007 | 3051 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1996 | 304 | 0.010 |
Why?
|
| Niacinamide | 1 | 1997 | 419 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2008 | 8725 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2002 | 1866 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1994 | 224 | 0.010 |
Why?
|
| Vitreous Body | 1 | 1996 | 399 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1977 | 770 | 0.010 |
Why?
|
| Microinjections | 1 | 1994 | 320 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2009 | 4862 | 0.010 |
Why?
|
| Species Specificity | 1 | 1997 | 2406 | 0.010 |
Why?
|
| Schizophrenia | 1 | 1991 | 6970 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1994 | 1300 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 502 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 6601 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1992 | 142 | 0.010 |
Why?
|
| Ion Channels | 1 | 1997 | 1044 | 0.010 |
Why?
|
| Software | 1 | 2006 | 4458 | 0.010 |
Why?
|
| Smoking | 1 | 2008 | 9081 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1997 | 848 | 0.010 |
Why?
|
| Gestational Age | 1 | 2000 | 3614 | 0.010 |
Why?
|
| Tissue Embedding | 1 | 1991 | 43 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1998 | 2199 | 0.010 |
Why?
|
| Psychosurgery | 1 | 1991 | 86 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1997 | 2511 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1982 | 3314 | 0.010 |
Why?
|
| Pokeweed Mitogens | 1 | 1990 | 37 | 0.010 |
Why?
|
| Substantia Innominata | 1 | 1990 | 23 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7476 | 0.010 |
Why?
|
| Phylogeny | 1 | 1997 | 2835 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 944 | 0.000 |
Why?
|
| Liver | 1 | 2004 | 7558 | 0.000 |
Why?
|
| Young Adult | 1 | 2015 | 59849 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 4961 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1994 | 2243 | 0.000 |
Why?
|
| Skin | 1 | 1981 | 4479 | 0.000 |
Why?
|
| Family | 1 | 1998 | 3208 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1990 | 20680 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1977 | 2464 | 0.000 |
Why?
|
| Obesity | 1 | 2008 | 13078 | 0.000 |
Why?
|
| Antigens, Surface | 1 | 1990 | 1617 | 0.000 |
Why?
|
| Agar | 1 | 1985 | 51 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1982 | 11643 | 0.000 |
Why?
|
| Tetanus Toxin | 1 | 1985 | 46 | 0.000 |
Why?
|
| Mucins | 1 | 1988 | 568 | 0.000 |
Why?
|
| Immunoglobulin M | 1 | 1990 | 1527 | 0.000 |
Why?
|
| Tetanus Toxoid | 1 | 1985 | 187 | 0.000 |
Why?
|
| Epithelium | 1 | 1988 | 1602 | 0.000 |
Why?
|
| Interleukin-2 | 1 | 1990 | 1896 | 0.000 |
Why?
|
| Infant | 2 | 2000 | 36375 | 0.000 |
Why?
|
| Immunization, Secondary | 1 | 1985 | 373 | 0.000 |
Why?
|
| Migraine Disorders | 1 | 1994 | 1730 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1990 | 2393 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2000 | 26337 | 0.000 |
Why?
|
| Depression | 1 | 1998 | 8224 | 0.000 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1977 | 91 | 0.000 |
Why?
|
| Acylation | 1 | 1977 | 98 | 0.000 |
Why?
|
| Pregnancy | 1 | 1998 | 30215 | 0.000 |
Why?
|
| Adenosine Diphosphate | 1 | 1977 | 419 | 0.000 |
Why?
|
| Epithelial Cells | 1 | 1988 | 3682 | 0.000 |
Why?
|
| Epinephrine | 1 | 1977 | 782 | 0.000 |
Why?
|
| HIV Infections | 1 | 1998 | 17530 | 0.000 |
Why?
|
| Aspirin | 1 | 1977 | 3135 | 0.000 |
Why?
|